Dr Reddy'S Laboratories Ltd header image

Dr Reddy'S Laboratories Ltd

RDY

Equity

ISIN null / Valor 1221723

New York Stock Exchange, Inc (2025-10-15)
USD 14.07+0.72%

Dr Reddy'S Laboratories Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Dr. Reddy's Laboratories Ltd is a global pharmaceutical company headquartered in India, engaged in the development, manufacture, and marketing of a wide range of pharmaceutical products. The company operates through various business segments including Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars, and over-the-counter (OTC) pharmaceutical products. Dr. Reddy's has a strong focus on meeting patient needs in several therapeutic areas such as gastroenterology, cardiovascular, diabetology, oncology, pain management, and dermatology. In addition to its existing product portfolio, the company is actively developing a pipeline of novel small molecules in immuno-oncology and working on differentiated products that aim to improve upon existing therapeutic agents. Furthermore, Dr. Reddy's is investing in emerging fields like digital therapeutics, cell, and gene therapies, indicating its commitment to innovation and addressing unmet medical needs.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-11.0%1Y
36.0%3Y
2.97%5Y

Performance

232%1Y
134%3Y
105%5Y

Volatility

Market cap

11711 M

Market cap (USD)

Daily traded volume (Shares)

1,088,508

Daily traded volume (Shares)

1 day high/low

15.85 / 15.68

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%USD 56.63
BrightSpring Health Services Inc
BrightSpring Health Services Inc BrightSpring Health Services Inc Valor: 131996976
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.74%USD 30.74
Sonova Holding Ltd.
Sonova Holding Ltd. Sonova Holding Ltd. Valor: 1254978
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.02%CHF 217.90
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.74%USD 4.64
Allogene Therapeutics Inc
Allogene Therapeutics Inc Allogene Therapeutics Inc Valor: 43756548
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.25%USD 1.27
TransMedics Group Inc
TransMedics Group Inc TransMedics Group Inc Valor: 47361695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%USD 112.61
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%SEK 254.70
Ensign Group Inc
Ensign Group Inc Ensign Group Inc Valor: 3109721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.03%USD 177.94
ACELYRIN INC
ACELYRIN INC ACELYRIN INC Valor: 126441937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 2.27
PACS Group Inc
PACS Group Inc PACS Group Inc Valor: 133777092
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.86%USD 12.69